Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,935 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trial.
Sporbeck B, Mathiske-Schmidt K, Jahr S, Huscher D, Becker M, Riemekasten G, Taufmann I, Burmester GR, Pögel S, Reisshauer A. Sporbeck B, et al. Among authors: becker m. Rheumatol Int. 2012 May;32(5):1469-73. doi: 10.1007/s00296-011-1882-2. Epub 2011 Apr 8. Rheumatol Int. 2012. PMID: 21476099 Clinical Trial.
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C; DNSS centers; Riemekasten G. Hanitsch LG, et al. Among authors: becker m. Rheumatology (Oxford). 2009 Jan;48(1):70-3. doi: 10.1093/rheumatology/ken408. Rheumatology (Oxford). 2009. PMID: 19056798
Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors.
Sunderkötter C, Herrgott I, Brückner C, Moinzadeh P, Pfeiffer C, Gerss J, Hunzelmann N, Böhm M, Krieg T, Müller-Ladner U, Genth E, Schulze-Lohoff E, Meurer M, Melchers I, Riemekasten G; DNSS Centers. Sunderkötter C, et al. Br J Dermatol. 2009 Apr;160(4):835-43. doi: 10.1111/j.1365-2133.2008.09004.x. Epub 2009 Jan 13. Br J Dermatol. 2009. PMID: 19183180
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.
Hanke K, Brückner CS, Dähnrich C, Huscher D, Komorowski L, Meyer W, Janssen A, Backhaus M, Becker M, Kill A, Egerer K, Burmester GR, Hiepe F, Schlumberger W, Riemekasten G. Hanke K, et al. Among authors: becker m. Arthritis Res Ther. 2009;11(1):R22. doi: 10.1186/ar2614. Epub 2009 Feb 16. Arthritis Res Ther. 2009. PMID: 19220911 Free PMC article.
Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort.
Hanke K, Dähnrich C, Brückner CS, Huscher D, Becker M, Jansen A, Meyer W, Egerer K, Hiepe F, Burmester GR, Schlumberger W, Riemekasten G. Hanke K, et al. Among authors: becker m. Arthritis Res Ther. 2009;11(1):R28. doi: 10.1186/ar2622. Epub 2009 Feb 21. Arthritis Res Ther. 2009. PMID: 19232127 Free PMC article.
Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis.
Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G. Krause L, et al. Among authors: becker c, becker mo. Ann Rheum Dis. 2010 Nov;69(11):1951-7. doi: 10.1136/ard.2009.123273. Epub 2010 May 28. Ann Rheum Dis. 2010. PMID: 20511612
3,935 results